Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: A trial from the University of Rochester Cancer Center Community Clinical Oncology Program
Oxana Palesh(Virginia Commonwealth University), Gary R. Morrow(University of Rochester Medical Center), Lisa K. Sprod(University of North Carolina Wilmington), Luke J. Peppone(University of Rochester Medical Center), Kevin Fiscella(University of Rochester), Shelli R. Kesler(The University of Texas at Austin), Pasquale F. Innominato(Betsi Cadwaladr University Health Board), Rachel Manber(Palo Alto University), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Michelle C. Janelsins(University of Rochester), Thomas Roth(INTEGRIS Baptist Medical Center)
Cited by 36
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Insomnia disorder
|Nature Reviews Disease Primers|2015|685